Pelizaeus–Merzbacher disease
(Redirected from Pelizaeus-Merzbacher disease)
Pelizaeus–Merzbacher disease (PMD) is a rare, progressive, degenerative central nervous system disorder in which coordination, motor abilities, and intellectual function deteriorate. It is one of a group of genetic disorders known as leukodystrophies, which are characterized by the degeneration of myelin, the fatty covering that insulates nerve fibers in the brain and spinal cord.
Classification[edit | edit source]
Pelizaeus–Merzbacher disease is classified into several types based on the severity and age of onset:
- Classic PMD: The most common form, presenting in early infancy.
- Connatal PMD: A more severe form, presenting at birth or shortly thereafter.
- Transitional PMD: Intermediate severity, with symptoms appearing in late infancy or early childhood.
- Adult PMD: A rare form with symptoms appearing in adulthood.
Symptoms[edit | edit source]
The symptoms of PMD vary depending on the type but generally include:
- Nystagmus (involuntary eye movement)
- Hypotonia (reduced muscle tone)
- Ataxia (lack of muscle coordination)
- Spasticity (stiff or rigid muscles)
- Delayed motor skills development
- Cognitive impairment
Genetics[edit | edit source]
Pelizaeus–Merzbacher disease is caused by mutations in the PLP1 gene located on the X chromosome. This gene is responsible for producing proteolipid protein 1, a critical component of myelin. PMD is inherited in an X-linked recessive pattern, meaning that males are more frequently affected, while females are typically carriers.
Diagnosis[edit | edit source]
Diagnosis of PMD involves a combination of clinical evaluation, magnetic resonance imaging (MRI) to detect abnormalities in the brain's white matter, and genetic testing to identify mutations in the PLP1 gene.
Treatment[edit | edit source]
There is currently no cure for Pelizaeus–Merzbacher disease. Treatment focuses on managing symptoms and may include:
- Physical therapy to improve motor skills and muscle strength
- Occupational therapy to assist with daily activities
- Speech therapy to address communication difficulties
- Medications to manage spasticity and other symptoms
Prognosis[edit | edit source]
The prognosis for individuals with PMD varies depending on the type and severity of the disease. While some individuals may have a relatively stable course, others may experience significant deterioration in motor and cognitive functions.
Related Pages[edit | edit source]
- Leukodystrophy
- Myelin
- X-linked recessive inheritance
- PLP1 gene
- Nystagmus
- Hypotonia
- Ataxia
- Spasticity
Categories[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD